Immediate Impact
9 from Science/Nature 61 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
Works of Ayush Arya being referenced
Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ayush Arya | 318 | 109 | 288 | 150 | 4 | 576 | |
| Matthew Winans | 243 | 47 | 273 | 207 | 7 | 622 | |
| Stephanie J. McAlhany | 249 | 246 | 400 | 94 | 8 | 734 | |
| Natanya R. Kerper | 345 | 72 | 223 | 312 | 4 | 654 | |
| Tianjian Lu | 327 | 67 | 216 | 166 | 5 | 628 | |
| Manuela Migliavacca | 451 | 83 | 299 | 163 | 10 | 720 | |
| Almudena Santos | 434 | 61 | 272 | 323 | 6 | 717 | |
| Caroline Contat | 159 | 76 | 369 | 213 | 5 | 684 | |
| Nina Sausgruber | 145 | 103 | 473 | 144 | 9 | 700 | |
| Paola Bianca | 315 | 99 | 329 | 114 | 6 | 617 | |
| Marina Ichetovkin | 201 | 110 | 316 | 42 | 6 | 625 |
All Works
Loading papers...